Dr. Rebecca Feldman on Caveolin-1 and its Potential in Breast Cancer Treatment
Rebecca Feldman, PhD, molecular science liaison/research scientist, Caris Life Sciences, discusses caveolin-1, which has the potential to play a major role in the treatment of breast cancer.
Rebecca Feldman, PhD, molecular science liaison/research scientist, Caris Life Sciences, discusses caveolin-1, which has the potential to play a major role in the treatment of breast cancer.
Feldman says that by targeting caveolin-1, medical professionals could potentially restrict the growth of breast cancer in a patient. She adds that by targeting caveolin-1 and restricting breast cancer growth, new treatments that target EGFR and PDGFRA could also become a possibility. This is due to caveolin-1’s role of signaling processes on the molecular level.
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen
